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Abstract: PTEX is the Plasmodium translocon of exported proteins of the malaria parasite 
(Plasmodium sp.) and functions to export proteins out of the parasite vacuolar membrane, 
remodeling the host erythrocyte. Remodeling enables the parasite to access vital nutrients and 
avoid immune defense of the host, enabling parasite survival and leading to malaria disease. 
A key protein interaction in PTEX involves 12 residues of component EXP2, which form an 
augmented β-sheet with component HSP101. Theoretically, interrupting this essential 
interaction by introducing a peptide corresponding to these 12 residues of EXP2 to compete 
with endogenous EXP2 would fatally damage the protein transport mechanism. If utilized 
therapeutically, this peptide could inhibit function of PTEX, thereby protecting host 
erythrocyte from parasitic use of nutrients and proteins, ultimately leading to parasite death. 
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Plasmodium parasites are responsible for malaria, the infectious disease that claimed over 
435,000 lives in 219 million cases worldwide in 20176. Plasmodium is transmitted between 
human and mosquito hosts/vectors with asexual human liver and blood stages and sexual 
mosquito states. Malaria disease occurs in the human host during the blood-stage of the infection 
when P. falciparum survives by invading and reproducing within human erythrocytes, then 
exporting hundreds of proteins to remodel the cell1. Plasmodium sporozoites reside in mosquito 
salivary glands and are introduced to host via mosquito during saliva deposit during bite. 
Sporozoites travel through bloodstream to the liver, infecting hepatocytes where they can 
replicate asexually. Asexually replicated sporozoites are termed merozoites. Merozoites are 
released into the bloodstream and infect host erythrocytes. During erythrocytic cycle, 
Plasmodium is encased within a vacuole, namely the parasitophorous vacuole. Parasite 
progresses through developmental stages within the parasitophorous vacuole, eventually forming 
a schizont to rupture and return merozoites to bloodstream. Gametocytes develop from 
Figure 1: Malaria Life Cycle, via CDC and Global Health, Division of Parasitic Diseases and Malaria 
Bartemes 3 
merozoites following each cycle of erythrocyte infection. Gametocytes are the sexual form of 
parasite and undergo five morphological stages prior to be taken as blood meal. Stage five 
gametocytes are taken by female Anopheles mosquito during blood meal and enter midgut of 
new host for sexual reproduction. Gametocytes differentiate into male and female microgametes 
and macrogametes, respectively. Fertilization forms zygote, maturing into ookinete that 
penetrates gut wall and develops to oocyst. Maturation of oocyst into sporozoites leads to release 
and migration to salivary gland. Life cycle repeats as mosquito takes another blood meal and 
deposits sporozoites1 (Figure 1). 
  To survive within the 
erythrocyte, a parasite needs 
access to an external 
environment from which to 
hijack nutrients. Through a 
complex and active mechanism, 
parasites enter erythrocytes and 
create a parasitophorous vacuole 
where they are protected from 
host immune system. Proteins 
necessary for parasite survival are unable to diffuse across the parasitophorous vacuolar 
membrane (PVM), and require the Plasmodium translocon of exported proteins (PTEX) for 
transport into the host cytosol1,4. The parasite exports proteins that remodel the red blood cell, 
enabling nutrient use and waste disposal. Erythrocyte remodeling as well as parasite metabolism 
require this export of protein with other small molecules across PVM3. Proteins traffic through 
the parasite secretory pathway to the vacuole and are recognized and transported across the PVM 
by PTEX1,4. PTEX is a recently discovered protein translocon located at the luminal face of the 
parasite vacuole membrane. PTEX requires ATP and unfolding of protein to cross PVM via 
PTEX (Figure 2). It is unknown if proteins are unfolded prior to entering PTEX or if PTEX 
facilitates unfolding within its components. PTEX operates in “hand-over-hand” mechanism, 
changing conformation to “pull” unfolded protein through pore and out to erythrocyte cytosol. 
Engaged state of PTEX is actively pulling unfolded protein through pore and then condenses into 
a slightly smaller resetting state, releasing to allow for protein to move through pore, then 
Figure 2: PTEX in engaged and resetting states unfolding and threading parasite 
protein cargo through pore. Nature 2018. 
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condenses again to continue along protein and ultimately thread protein through pore (Figure 3). 
Most proteins are then free to refold with exit into erythrocyte cytosol.  
PTEX is a triad of core components – AAA+ ATPase heat shock protein 101 (HSP101), 
exported protein 2 (EXP2), and PTEX1504. 
These three proteins are essential for the 
survival of the parasite, as their function 
allows for parasite protein and nutrient 
availability. The three core components of 
PTEX form a stable complex within both 
parasitophorous vacuole membrane and 
parasite plasma membrane. HSP101 is made 
up of six individual pseudo-symmetrical 
subunits, while EXP2 and PTEX150 are 
made up of seven individual pseudo-
symmetrical subunits (Figure 4).  
 
Figure 4: PTEX is a triad of three components each 
with their own subunits creating a pseudo-symmetrical 
interlocking conformation. Nature 2018 
Figure 3: Engaged and resetting states of PTEX. PTEX condenses and resets as it threads unfolded protein through pore and 
into erythrocyte cytosol in “hand-over-hand” mechanism. Nature 2018. 
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 Interactions essential for PTEX function include a C-terminal domain of EXP2 and β-
sheet of HSP101 with EXP2 promoter. This interaction forms an augmented β-sheet within each 
component subunit, for six total interactions within PTEX. These interactions are key for the 
stable assembly of the PTEX core complex. Total knockdown of EXP2 produced lethal defect in 
P. falciparum growth and export1, but an EXP2 knockdown is rescued by the introduction of 
mutant EXP2 complete with 54 residues. However, a mutant lacking final 12 residues does not 
rescue parasite with EXP2 knockdown4. This shows the final 12 residues of C-terminus EXP2 
within augmented β-sheet are the essential feature of interaction. Prior to, and following 54 
residues, amino acids are not directly responsible for PTEX function4 (Figure 5). Because there 
are six subunits of HSP101 and seven subunits of EXP2 within each PTEX, six interactions 
between HSP101 and EXP2 are taking place among the translocon in psudo-symmetrical 
increments. 
 Disruption of the 12 crucial residues of EXP2 with HSP101 augmented β-sheet would 
inhibit function of PTEX. In order to create disruption, an exogenous EXP2 peptide will be 
introduced to compete with endogenous EXP2. This peptide would operate as a block, 
Figure 5: Interaction between HSP101 and EXP2 form an augmented β-sheet essential for the function of PTEX. C-
terminus 12 residues in conformation with HSP101 are the true essentials and anything prior (red highlight) or 
following those amino acids do not contribute to PTEX functional interruption. Nature 2018 
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preventing formation of augmented β-sheet. Without augmented β-sheet, EXP2 and HSP101 
would have no interaction among any PTEX component subunits, inhibiting function of 
translocon, and thereby preventing any protein export. Eventually, this competitive inhibition 
would theoretically result in parasite death following lack of resources. Within a conditional 
system, parasite death can be linked to conditional expression of exogenous EXP2 peptide. 
To transfect exogenous EXP2 peptide into parasitic line, sequence must be introduced 
into plasmid and transformed into DNA. One plasmid received two different inserts in two 
separate experiments to test hypothesis of disruption of endogenous EXP2 to competitively 
inhibit PTEX. Plasmid pLN-HSP101-SP-mRuby3 utilized for PCR mutagenesis to insert 
EXP2_222-233 and EXP2_222-233 scrambled. This plasmid was chosen for presence of 
mRuby3 fluorescence protein and signaling peptide. The signaling peptide has been previously 
shown to appropriately flag proteins for export by PTEX, guaranteeing interaction between 
exogenous insert and endogenous PTEX machinery. Fluorescent tag mRuby3 is useful as partner 
with EXP2 peptides as the EXP2 peptide is only approximately 50 residues and small peptides 
have risk of becoming lost within parasitic cytosol. mRuby3 tag will operate both as a well-
folded chaperone protein for potential export through PTEX and as florescent tag following 
transfection into parasite line. Scrambled version of EXP2 is proof of concept of specific 12 
amino acid sequence required for interaction. The scrambled EXP2 peptide would be 
theoretically unable to compete with endogenous EXP2 because it could not form required 
augmented β-sheet, rescuing parasite. Placement into plasmid pLN-HSP101-SP-mRuby3 is 
deemed “The Easy Way” due to commonly used plasmid and comparative “The Hard Way”. The 
Hard Way involves a long, linear plasmid not often used but contains a conditional repression 
system. This plasmid, psn154_pfcrt_HA-FKBP-dCas9-FLUC+hyp12 flanks is 30kb and contains 
the TetR-DOZI-aptamer system as the conditional knockout system (Figure 6). With this 
approach, parasite survival and death can be observed as a result of the introduced exogenous 
peptide expression, “turning off and on”, respectively. Turning the conditional system “on” will 
lead to the expression of competitive EXP2, effectively killing the parasite due to PTEX 
dysfunction.  
The TetR (Tet-repressor protein) DOZI (development of zygote inhibited)5  aptamer 
conditional knockout system uses the addition of anhydrotetracycline (aTc)2  as conditional 
switch. Addition of aTc allows transcription and subsequent translation of EXP2 by binding to 
Bartemes 7 
TetR-DOZI, ceasing repression of RNA polymerase. Without the addition of aTc, EXP2 will not 
be translated due to RNA polymerase inhibition and the exogenous EXP2 peptide will not be 
available to compete with endogenous EXP2. Lack of competition allows parasite within 
erythrocyte to normally function via PTEX and continue to proliferate. The presence of this 
system will allow direct observations of the successful competitive interaction of exogenous 
EXP2 over endogenous EXP2.  
 
T 
This is an ongoing experiment in the Beck Lab and will hopefully produce results within 
the coming weeks. The expected result following transfection is no proliferation of EB1 (non-
scrambled) and viable EB2 (non-scrambled) within pLN-HSP101-SP-mRuby3 plasmid. The EB1 
strain is not expected to grow because it will be unable to remodel the erythrocyte to hijack vital 
nutrients and proteins. If the observed result is as expected, research will move forward with 
“hard way” plasmid containing conditional knockout system. 
Quick Change Lightning Multi Site Mutagenesis PCR with primers EB1 (non-scrambled) 
and EB2 (scrambled) were performed to introduce EXP2_222-233 non-scrambled insert and 
EXP2_222-233 scrambled insert to pLN-HSP101-SP-mRuby3. PrimeStar GXLDNA polymerase 
PCR reaction protocol was used to produce plasmid for E. coli mutagenesis and transformation. 
Primers used were 100 base pairs long and approximately 25 µg per OD. Primer EB1 was used 
for non-scrambled insert and primer EB2 used for scrambled insert. PCR mutagenesis used quick 
Figure 6: Schematic of TetR-DOZI-aptamer repression system to be used in the future of the study. 
TetR-DOZI-aptamer will allow the “on/off switch” with application of aTc to media. Nature 
Microbiology, 2018. 
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change lightning buffer, water, quick solution, primers, and quick change lightning enzyme 
blend in addition to parent plasmid DNA, according to protocol. DpnI digest was applied to PCR 
mix following PCR cycle. The two new plasmids, non-scrambled and scrambled (EB1 and EB2, 
respectively), undergo transformation into XL 10Gold ultra-competent Escherichia coli with β-
MercaptoEtOH (β-ME). β-ME reduces disulfide bonds to deactivate nucleases so DNA is 
conserved. 100μL of plasmid DNA with inserts are grown on Ampicillin-resistant agar plates for 
24 hours. Following 24-hour incubation and successful growth, colonies were picked and mini-
preps were performed to isolate DNA and prove presence of insert within plasmid via Sanger 
sequencing. Mini-prep procedure was utilized multiple times because electrophoresis gel often 
did not show significant evidence of presence of insert within plasmid. Gel electrophoresis 
process digested plasmids cut by specific enzymes to locate newly introduced insert. EB1 digest 
utilized NheI and AflII enzymes, and EB2 utilized PacI enzyme. Colonies A-F of EB1 and EB2 
were not successfully transformed. Colonies G-L of EB1 was not successfully transformed, 
however, EB2-H showed evidence, upon gel electrophoresis, of successful transformation. DNA 
for sequencing was submitted to Iowa State DNA Facility and sequencing matched, proving 
presence of insert within plasmid (successful transformation – Figure 7). EB2-G, I-L colonies 
were all unsuccessful. Colonies M-Q, 1-10, and AA-AN of EB1 were also unsuccessful. 
Fortunately, colony AO was clearly positive for successful transformation on gel electrophoresis, 
and Sanger sequencing via Iowa State DNA Facility confirmed correct sequence (Figure 8). 





Figure 7: EB2 Colony H positive sequencing gel electrophoresis result. Parent digested in this study was 
incorrect and a subsequent digest to view PacI enzyme cut sites was performed to understand two cut 
sites observed. Plasmid contains two PacI cut sites and a slightly higher band is observed to qualify for 
DNA sequencing. Sanger sequencing confirmed correct DNA sequence and positive presence of peptide 
insert within plasmid. 
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During the course of isolating colonies and digesting to find confirmed transformed plasmid, 
several adjustments and corrections were made. The first four digests (EB1, EB2 E-F and EB1, 
EB2 G-L) used the incorrect parent. The parent used was the “Hard Way” though was thought to 
be the “Easy Way”. Additionally, EB1 A-F were originally digested with BseGI and AflII but 
did not show positive result so chose to use NheI in place of BseGI for future digests.  
Newly synthesized DNA containing desired insert (EB1-AO and EB2-H) transfected into 
known plasmodium falciparum strain with blasticidin (BSD) to be observed. If EB1 parasites are 
not successful and do not proliferate, “Hard Way” will be carried out to prove the presence of 
exogenous EXP2 peptide is the reason for result. Transfection carried out via electroporation 
with BioRad Gene Pulser II. Electroporation is the technique in which an electric current is 
applied to cells to briefly open cell membranes via pores to introduce new DNA or chromosomes 
into bacteria. Plasmid DNA prepared with 1X and 2X cytomix to replicate erythrocyte cytosol 
condition and increase transfection chance of success. Parasites were transfected at equivalent of 
~5% parasitemia of 2% hematocrit culture in ring stage. Cells suspended in media and treated 
with BSD selection after 24 hours for better conditions. 
This research and further research in similar capacity could be utilized therapeutically to 
produce a drug that introduces exogenous peptide to interrupt function of PTEX. Unfortunately, 
Figure 8: EB Colony AO positive sequencing gel electrophoresis result. Slightly higher band for AO 
indicates a heavier segment of DNA due to an increased number of base pairs. Therefore, the presence of 
inserted peptide within plasmid is highly suspected. DNA Sanger sequencing confirms presence of insert. 
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this drug would only treat patients already infected with malaria. Additionally, the drug would 
only be targeting Plasmodium while in erythrocyte stages, and would have no effect on any 
parasite within hepatocytes, presenting a narrow and hard to track therapeutic window. Malaria 
is a devastating disease and recently progress in the form of decreasing cases and deaths per year 
has stagnated. Any promising research is worth studying to help rid the world of this destruction 
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